Studies have shown that σ2R/TMEM97 ligands may also be useful in the treatment of a number of neurologic disorders, including Huntington disease (28), neuropathic pain (29), and Alzheimer disease (30). Here, TMEM97 is linked to early-onset autosomal dominant Alzheimer disease.